Balsamiq: 16-Year-Old Wireframing Tool Publishes Its Own $6.58M Revenue — Including an "Intentional Decline"

“Our 2024 revenue clocked in at $6.58M USD, a 6% dip from 2023 (expected and close to last year’s forecast.” Balsamiq, the wireframing tool, writes this in its own annual report series, “Looking back.” Not a growth brag) a report of decline. And for 2025, the company even adds that it expects “another slight, intentional dip with profitability intact.”

Balsamiq was founded in 2008. Rather than rendering polished UI mockups, it deliberately specializes in “hand-drawn-style rough sketches,” sold for over a decade and a half by a small, remote-first team with zero outside funding. According to the company page, more than 16,000 product teams use it every month, and it has been sold over 1.4 million times across 204 countries and territories. In a market dominated by Figma and AI design tools, this is a rare case where you can track how a single-purpose veteran maintains its numbers, through its own annual disclosures.

The published numbers

• 2008: Founded. Bootstrapped and remote-first ever since
• 2023: Revenue of $6,994,596 (down 3.6% YoY)
• 2024: Revenue of $6.58M (down 6% YoY) — “expected,” in the company’s own words
• 2025 (forecast): Another slight, intentional decline with profitability intact
• Usage: 16,000+ teams monthly; 1.4M+ cumulative sales in 204 countries

In the 2024 report, the company sums up the year in three verbs. “Pruned” meant discontinuing the Google Drive version and beginning to wind down Desktop. “Focused” meant concentrating on Balsamiq Cloud and the Atlassian integrations for Jira and Confluence. “Adapted” meant embracing data analytics “after years of resisting it,” in their own words. On the product side: a new 10-project plan for growing teams, a new sketch style, better snapping and alignment, and overhauled templates for sprints and dashboards.

The 2023 edition reads the same way. Alongside revenue stated to the dollar ($6,994,596) it calmly records feature improvements like the new app bar and mini-map canvas, the “Salary Matrix” compensation system aligning titles and pay, and the publication of their book, Wireframing for Everyone. The first full year of Group Managers is summed up as “an internal survey showed a happier team and better productivity”, the report covers organizational experiments as much as revenue. The book itself is a form of education-driven acquisition: instead of buying ads, they wrote the textbook for wireframing itself.

The structure that makes decline publishable

This posture of disclosure is better read as a consequence of business structure than as a virtue.

The base condition is the absence of outside capital. With no growth story to sell to shareholders, revenue can be a number that confirms survival rather than one that gets judged. The company page codifies “Longevity over hypergrowth,” and reporting a decline is a live demonstration of that value. Among our covered cases, Transistor reaching $1M ARR under its “calm company” banner sits in the same lineage.

The decline itself, moreover, is part of the plan. The 2024 report calls this moment the company’s “third ceiling moment in 15 years.” Killing the Google Drive version and winding down Desktop are decisions that reliably cut short-term revenue. Far from being neglect, the 6% dip was priced in from the start as the cost of pruning the product line. The phrase “intentional decline” only works because profitability and cash cushion come first.

The remaining piece is the choice of niche. Balsamiq does not compete with Figma on features. It stays put on the single point of “low-fidelity sketching.” The 2024 report notes that a UX competitor shut down and that others struggled to adapt in the face of AI, while remaining “optimistic about our niche.” Surviving by narrowing scope echoes Carrd’s “don’t add features” strategy on its way to $2M ARR as a solo product.

Disclosure is also editorial

Before taking this transparency at face value, a few caveats.

The decline is now two years running: down 3.6% in 2023, 6% in 2024, with 2025 also planned down. The “intentional” framing is internally consistent today, but the difference between chosen shrinkage and being squeezed by the market can only be verified after the fact. The possibility that wireframing itself gets absorbed by AI design tools is a headwind the company acknowledges. And “finally adopting data analytics after years of resisting it” can be read in reverse: a self-diagnosis that intuition and conversation alone no longer clear the ceiling.

Also, what is disclosed is mostly top-line revenue, no profit figures, churn rates, or per-plan breakdowns. Even a company that publishes numbers every year edits what it shows. The structural risk of a single-purpose tool being absorbed by platform feature creep also remains: the focus on Atlassian integrations is a channel, and simultaneously a dependency on someone else’s turf.

What transfers, and what doesn’t

The operating condition for publishing annual numbers is the part any company can copy: if a company has no outside capital and doesn’t fundraise on those numbers, disclosure doubles as sales collateral and recruiting PR at low risk. Balsamiq’s annual report functions as a machine that generates news for an 18-year-old product every single year, imitable at any scale. Healthchecks.io, run by one person for 11 years while continuously publishing $22,600 MRR, shows the same effect: sustained disclosure becomes an asset of trust.

By contrast, being able to choose an intentional decline has strict prerequisites: profitability, cash, and a base of customers who won’t collapse when you shrink. Only with all three can revenue-cutting product pruning be called a “plan.” At $6.58M in year 16, Balsamiq is among the largest SaaS cases we cover, and even at that scale, it writes that this is its third ceiling. When a small business lasts long, its story becomes a record of pruning and choices rather than growth. That is what the Looking back series actually shows.